nach oben

Journal of Neural Transmission

Erschienen in:

17.05.2017 | Neurology and Preclinical Neurological Studies - Review Article

In vivo PET imaging of neuroinflammation in Alzheimer’s disease

verfasst von: Julien Lagarde, Marie Sarazin, Michel Bottlaender

Erschienen in: Journal of Neural Transmission | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Increasing evidence suggests that neuroinflammation contributes to the pathophysiology of many neurodegenerative diseases, especially Alzheimer’s disease (AD). Molecular imaging by PET may be a useful tool to assess neuroinflammation in vivo, thus helping to decipher the complex role of inflammatory processes in the pathophysiology of neurodegenerative diseases and providing a potential means of monitoring the effect of new therapeutic approaches. For this objective, the main target of PET studies is the 18 kDa translocator protein (TSPO), as it is overexpressed by activated microglia. In the present review, we describe the most widely used PET tracers targeting the TSPO, the methodological issues in tracer quantification and summarize the results obtained by TSPO PET imaging in AD, as well as in neurodegenerative disorders associated with AD, in psychiatric disorders and ageing. We also briefly describe alternative PET targets and imaging modalities to study neuroinflammation. Lastly, we question the meaning of PET imaging data in the context of a highly complex and multifaceted role of neuroinflammation in neurodegenerative diseases. This overview leads to the conclusion that PET imaging of neuroinflammation is a promising way of deciphering the enigma of the pathophysiology of AD and of monitoring the effect of new therapies.

Ahamed M, van Veghel D, Ullmer C, Van Laere K, Verbruggen A, Bormans GM (2016) Synthesis, biodistribution and in vitro evaluation of brain permeable high affinity type 2 cannabinoid receptor agonists [¹¹C]MA2 and [¹⁸F]MA3. Front Neurosci 10:431PubMedPubMedCentralCrossRef

Ahmad R, Postnov A, Bormans G, Versijpt J, Vandenbulcke M, Van Laere K (2016) Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease. Eur J Nucl Med Mol Imaging 43(12):2219–2227PubMedCrossRef

Albrecht DS, Granziera C, Hooker JM, Loggia ML (2016) In vivo imaging of human neuroinflammation. ACS Chem Neurosci 7(4):470–483PubMedCrossRef

Anderson AN, Pavese N, Edison P, Tai YF, Hammers A, Gerhard A, Brooks DJ, Turkheimer FE (2007) A systematic comparison of kinetic modelling methods generating parametric maps for [¹¹C]-(R)-PK11195. Neuroimage 36(1):28–37PubMedCrossRef

Banati RB (2002) Visualising microglial activation in vivo. Glia 40:206–217PubMedCrossRef

Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123(Pt 11):2321–2337PubMedCrossRef

Belloli S, Moresco RM, Matarrese M, Biella G, Sanvito F, Simonelli P, Turolla E, Olivieri S, Cappelli A, Vomero S, Galli-Kienle M, Fazio F (2004) Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration. Neurochem Int 44:433–440PubMedCrossRef

Bloomfield PS, Selvaraj S, Veronese M, Rizzo G, Bertoldo A, Owen DR, Bloomfield MA, Bonoldi I, Kalk N, Turkheimer F, McGuire P, de Paola V, Howes OD (2016) Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [¹¹C]PBR28 PET brain imaging study. Am J Psychiatry 173(1):44–52PubMedCrossRef

Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB (2001) In-vivo measurement of activated microglia in dementia. Lancet 358(9280):461–467PubMedCrossRef

Cagnin A, Rossor M, Sampson EL, Mackinnon T, Banati RB (2004) In vivo detection of microglial activation in frontotemporal dementia. Ann Neurol 56(6):894–897PubMedCrossRef

Cai Z, Hussain MD, Yan LJ (2014) Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease. Int J Neurosci 124(5):307–321PubMedCrossRef

Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A (2012) Evidence for astrocytosis in prodromal Alzheimer disease provided by ¹¹C-deuterium-l-deprenyl: a multitracer PET paradigm combining ¹¹C-Pittsburgh compound B and ¹⁸F-FDG. J Nucl Med 53(1):37–46PubMedCrossRef

Casellas P, Galiegue S, Basile AS (2002) Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 40:475–486PubMedCrossRef

Chauveau F, Van Camp N, Dollé F, Kuhnast B, Hinnen F, Damont A, Boutin H, James M, Kassiou M, Tavitian B (2009) Comparative evaluation of the translocator protein radioligands ¹¹C-DPA-713, ¹⁸F-DPA-714, and ¹¹C-PK11195 in a rat model of acute neuroinflammation. J Nucl Med 50(3):468–476PubMedCrossRef

Ching AS, Kuhnast B, Damont A, Roeda D, Tavitian B, Dollé F (2012) Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases. Insights Imaging 3(1):111–119PubMedCrossRef

Choo IL, Carter SF, Schöll ML, Nordberg A (2014) Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer’s patients. Eur J Nucl Med Mol Imaging 41(11):2120–2126PubMedCrossRef

Corcia P, Tauber C, Vercoullie J, Arlicot N, Prunier C, Praline J, Nicolas G, Venel Y, Hommet C, Baulieu JL, Cottier JP, Roussel C, Kassiou M, Guilloteau D, Ribeiro MJ (2012) Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS One 7(12):e52941PubMedPubMedCentralCrossRef

Cosenza-Nashat M, Zhao ML, Suh HS, Morgan J, Natividad R, Morgello S, Lee SC (2009) Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol 35(3):306–328PubMedCrossRef

Cunningham VJ, Hume SP, Price GR, Ahier RG, Cremer JE, Jones AK (1991) Compartmental analysis of diprenorphine binding to opiate receptors in the rat in vivo and its comparison with equilibrium data in vitro. J Cereb Blood Flow Metab 11(1):1–9PubMedCrossRef

Di Grigoli G, Monterisi C, Belloli S, Masiello V, Politi LS, Valenti S, Paolino M, Anzini M, Matarrese M, Cappelli A, Moresco RM (2015) Radiosynthesis and preliminary biological evaluation of [¹⁸F]VC701, a radioligand for translocator protein. Mol Imaging. doi:10.2310/7290.2015.00007 PubMedCrossRef

Diorio D, Welner SA, Butterworth RF, Meaney MJ, Suranyi-Cadotte BE (1991) Peripheral benzodiazepine binding sites in Alzheimer’s disease frontal and temporal cortex. Neurobiol Aging 12(3):255–258PubMedCrossRef

Doble A, Malgouris C, Daniel M, Daniel N, Imbault F, Basbaum A, Uzan A, Guérémy C, Le Fur G (1987) Labelling of peripheral-type benzodiazepine binding sites in human brain with [³H]PK 11195: anatomical and subcellular distribution. Brain Res Bull 18(1):49–61PubMedCrossRef

Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC (2009) Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 50(11):1801–1807PubMedCrossRef

Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE, Hammers A, Tai YF, Fox N, Kennedy A, Rossor M, Brooks DJ (2008) Microglia, amyloid, and cognition in Alzheimer’s disease: an [¹¹C](R)PK11195-PET and [¹¹C]PIB-PET study. Neurobiol Dis 32(3):412–419PubMedCrossRef

Edison P, Ahmed I, Fan Z, Hinz R, Gelosa G, Ray Chaudhuri K, Walker Z, Turkheimer FE, Brooks DJ (2013) Microglia, amyloid, and glucose metabolism in Parkinson’s disease with and without dementia. Neuropsychopharmacology 38(6):938–949PubMedPubMedCentralCrossRef

Endres CJ, Pomper MG, James M, Uzuner O, Hammoud DA, Watkins CC, Reynolds A, Hilton J, Dannals RF, Kassiou M (2009) Initial evaluation of ¹¹C-DPA-713, a novel TSPO PET ligand, in humans. J Nucl Med 50:1276–1282PubMedCrossRef

Esposito G, Giovacchini G, Liow JS, Bhattacharjee AK, Greenstein D, Schapiro M, Hallett M, Herscovitch P, Eckelman WC, Carson RE, Rapoport SI (2008) Imaging neuroinflammation in Alzheimer’s disease with radiolabeled arachidonic acid and PET. J Nucl Med 49(9):1414–1421PubMedCrossRef

Fan Z, Aman Y, Ahmed I, Chetelat G, Landeau B, Ray Chaudhuri K, Brooks DJ, Edison P (2015a) Influence of microglial activation on neuronal function in Alzheimer’s and Parkinson’s disease dementia. Alzheimers Dement 11(6):608–621.e7PubMedCrossRef

Fan Z, Harold D, Pasqualetti G, Williams J, Brooks DJ, Edison P (2015b) Can studies of neuroinflammation in a TSPO genetic subgroup (HAB or MAB) be applied to the entire AD cohort? J Nucl Med 56(5):707–713PubMedCrossRef

Fan Z, Okello AA, Brooks DJ, Edison P (2015c) Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer’s disease. Brain 138(Pt 12):3685–3698PubMedCrossRef

Fan Z, Calsolaro V, Atkinson RÁ, Femminella GD, Waldman A, Buckley C, Trigg W, Brooks DJ, Hinz R, Edison P (2016) Flutriciclamide (¹⁸F-GE180) PET: first in human PET study of novel 3rd generation in vivo marker of human translator protein. J Nucl Med 57(11):1753–1759PubMedCrossRef

Fan Z, Brooks DJ, Okello A, Edison P (2017) An early and late peak in microglial activation in Alzheimer’s disease trajectory. Brain. doi:10.1093/brain/aww349 PubMedCentralCrossRefPubMed

Femminella GD, Ninan S, Atkinson R, Fan Z, Brooks DJ, Edison P (2016) Does microglial activation influence hippocampal volume and neuronal function in Alzheimer’s disease and Parkinson’s disease dementia? J Alzheimers Dis 51(4):1275–1289PubMedCrossRef

García-Lorenzo D, Lavisse S, Leroy C, Wimberley C, Bodini B, Remy P, Veronese M, Turkheimer F, Stankoff B, Bottlaender M (2017) Validation of an automatic reference region extraction for the quantification of [¹⁸F]DPA-714 in dynamic brain PET studies. J Cereb Blood Flow Metab. doi:10.1177/0271678X17692599 CrossRefPubMedPubMedCentral

Gauberti M, Montagne A, Quenault A, Vivien D (2014) Molecular magnetic resonance imaging of brain-immune interactions. Front Cell Neurosci 8:389PubMedPubMedCentralCrossRef

Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A (1999) Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 51:629–650PubMed

Gerhard A, Banati RB, Goerres GB, Cagnin A, Myers R, Gunn RN, Turkheimer F, Good CD, Mathias CJ, Quinn N, Schwarz J, Brooks DJ (2003) [¹¹C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 61(5):686–689PubMedCrossRef

Gerhard A, Watts J, Trender-Gerhard I, Turkheimer F, Banati RB, Bhatia K, Brooks DJ (2004) In vivo imaging of microglial activation with [¹¹C](R)-PK11195 PET in corticobasal degeneration. Mov Disord 19(10):1221–1226PubMedCrossRef

Gerhard A, Trender-Gerhard I, Turkheimer F, Quinn NP, Bhatia KP, Brooks DJ (2006) In vivo imaging of microglial activation with [¹¹C](R)-PK11195 PET in progressive supranuclear palsy. Mov Disord 21(1):89–93PubMedCrossRef

Gershen LD, Zanotti-Fregonara P, Dustin IH, Liow JS, Hirvonen J, Kreisl WC, Jenko KJ, Inati SK, Fujita M, Morse CL, Brouwer C, Hong JS, Pike VW, Zoghbi SS, Innis RB, Theodore WH (2015) Neuroinflammation in temporal lobe epilepsy measured using positron emission tomographic imaging of translocator protein. JAMA Neurol 72(8):882–888PubMedPubMedCentralCrossRef

Golla SS, Boellaard R, Oikonen V, Hoffmann A, van Berckel BN, Windhorst AD, Virta J, Haaparanta-Solin M, Luoto P, Savisto N, Solin O, Valencia R, Thiele A, Eriksson J, Schuit RC, Lammertsma AA, Rinne JO (2015) Quantification of [¹⁸F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer’s disease patients. J Cereb Blood Flow Metab 35(5):766–772PubMedPubMedCentralCrossRef

Golla SS, Boellaard R, Oikonen V, Hoffmann A, van Berckel BN, Windhorst AD, Virta J, Te Beek ET, Groeneveld GJ, Haaparanta-Solin M, Luoto P, Savisto N, Solin O, Valencia R, Thiele A, Eriksson J, Schuit RC, Lammertsma AA, Rinne JO (2016) Parametric binding images of the TSPO ligand ¹⁸F-DPA-714. J Nucl Med 57(10):1543–1547PubMedCrossRef

Groom GN, Junck L, Foster NL, Frey KA, Kuhl DE (1995) PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer’s disease. J Nucl Med 36(12):2207–2210PubMed

Gulyas B, Toth M, Vas A, Shchukin E, Kostulas K, Hillert J, Halldin C (2012) Visualising neuroinflammation in post-stroke patients: a comparative PET study with the TSPO molecular imaging biomarkers [¹¹C]PK11195 and [¹¹C]vinpocetine. Curr Radiopharm 5(1):19–28PubMedCrossRef

Gulyás B, Makkai B, Kása P, Gulya K, Bakota L, Várszegi S, Beliczai Z, Andersson J, Csiba L, Thiele A, Dyrks T, Suhara T, Suzuki K, Higuchi M, Halldin C (2009) A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system. Neurochem Int 54(1):28–36PubMedCrossRef

Gulyás B, Pavlova E, Kása P, Gulya K, Bakota L, Várszegi S, Keller E, Horváth MC, Nag S, Hermecz I, Magyar K, Halldin C (2011a) Activated MAO-B in the brain of Alzheimer patients, demonstrated by [¹¹C]-l-deprenyl using whole hemisphere autoradiography. Neurochem Int 58(1):60–68PubMedCrossRef

Gulyás B, Vas A, Tóth M, Takano A, Varrone A, Cselényi Z, Schain M, Mattsson P, Halldin C (2011b) Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [¹¹C]vinpocetine. Neuroimage 56(3):1111–1121PubMedCrossRef

Guo Q, Colasanti A, Owen DR, Onega M, Kamalakaran A, Bennacef I, Matthews PM, Rabiner EA, Turkheimer FE, Gunn RN (2013) Quantification of the specific translocator protein signal of ¹⁸F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding. J Nucl Med 54(11):1915–1923PubMedCrossRef

Haarman BC, Riemersma-Van der Lek RF, de Groot JC, Ruhé HG, Klein HC, Zandstra TE, Burger H, Schoevers RA, de Vries EF, Drexhage HA, Nolen WA, Doorduin J (2014) Neuroinflammation in bipolar disorder—a [¹¹C]-(R)-PK11195 positron emission tomography study. Brain Behav Immun 40:219–225PubMedCrossRef

Hafizi S, Tseng HH, Rao N, Selvanathan T, Kenk M, Bazinet RP, Suridjan I, Wilson AA, Meyer JH, Remington G, Houle S, Rusjan PM, Mizrahi R (2017) Imaging microglial activation in untreated first-episode psychosis: a pet study with [¹⁸F]FEPPA. Am J Psychiatry 174:118–124PubMedCrossRef

Hagens M, van Berckel B, Barkhof F (2016) Novel MRI and PET markers of neuroinflammation in multiple sclerosis. Curr Opin Neurol 29(3):229–236PubMedCrossRef

Hamelin L, Lagarde J, Dorothée G, Leroy C, Labit M, Comley RA, de Souza LC, Corne H, Dauphinot L, Bertoux M, Dubois B, Gervais P, Colliot O, Potier MC, Bottlaender M, Sarazin M, Clinical IMABio3 Team (2016) Early and protective microglial activation in Alzheimer’s disease: a prospective study using ¹⁸F-DPA-714 PET imaging. Brain 139(Pt 4):1252–1264PubMedCrossRef

Hannestad J, DellaGioia N, Gallezot JD, Lim K, Nabulsi N, Esterlis I, Pittman B, Lee JY, O’Connor KC, Pelletier D, Carson RE (2013) The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [¹¹C]PBR28 PET study. Brain Behav Immun 33:131–138PubMedPubMedCentralCrossRef

Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14(4):388–405PubMedCrossRefPubMedCentral

Henkel K, Karitzky J, Schmid M, Mader I, Glatting G, Unger JW, Neumaier B, Ludolph AC, Reske SN, Landwehrmeyer GB (2004) Imaging of activated microglia with PET and [¹¹C]PK 11195 in corticobasal degeneration. Mov Disord 19(7):817–821PubMedCrossRef

Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16(6):358–372PubMedCrossRef

Herranz E, Hooker JM, Izquierdo-Garcia D, Loggia ML, Mainero C (2017) Reply. Ann Neurol 81(2):324–325PubMedCrossRef

Hickman SE, El Khoury J (2014) TREM2 and the neuroimmunology of Alzheimer’s disease. Biochem Pharmacol 88(4):495–498PubMedCrossRef

Hillmer AT, Li S, Zheng MQ, Scheunemann M, Lin SF, Nabulsi N, Holden D, Pracitto R, Labaree D, Ropchan J, Teodoro R, Deuther-Conrad W, Esterlis I, Cosgrove KP, Brust P, Carson RE, Huang Y (2017) PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [¹⁸F]-ASEM and [¹⁸F]-DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans. Eur J Nucl Med Mol Imaging. doi:10.1007/s00259-017-3621-8 PubMedCrossRefPubMedCentral

Hinz R, Boellaard R (2015) Challenges of quantification of TSPO in the human brain. DOI, Clin Transl Imaging. doi:10.1007/s40336-015-0138-7 CrossRef

Hirvonen J, Kailajärvi M, Haltia T, Koskimies S, Någren K, Virsu P, Oikonen V, Sipilä H, Ruokoniemi P, Virtanen K, Scheinin M, Rinne JO (2009) Assessment of MAO-B occupancy in the brain with PET and [¹¹C]-l-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301. Clin Pharmacol Ther 85(5):506–512PubMedCrossRef

Hommet C, Mondon K, Camus V, Ribeiro MJ, Beaufils E, Arlicot N, Corcia P, Paccalin M, Minier F, Gosselin T, Page G, Guilloteau D, Chalon S (2014) Neuroinflammation and β amyloid deposition in Alzheimer’s disease: in vivo quantification with molecular imaging. Dement Geriatr Cogn Disord 37(1–2):1–18PubMedCrossRef

Iannaccone S, Cerami C, Alessio M, Garibotto V, Panzacchi A, Olivieri S, Gelsomino G, Moresco RM, Perani D (2013) In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson’s disease. Parkinsonism Relat Disord 19(1):47–52PubMedCrossRef

Ikawa M, Lohith TG, Shrestha S, Telu S, Zoghbi SS, Castellano S, Taliani S, Da Settimo F, Fujita M, Pike VW, Innis RB (2017) ¹¹C-ER176, a radioligand for 18-kDa translocator protein (TSPO), has adequate sensitivity to robustly image all three affinity genotypes in human brain. J Nucl Med 58:320–325PubMedPubMedCentralCrossRef

Janssen B, Vugts DJ, Funke U, Spaans A, Schuit RC, Kooijman E, Rongen M, Perk LR, Lammertsma AA, Windhorst AD (2014) Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [¹¹C]A-740003 as a novel tracer of neuroinflammation. J Label Comp Radiopharm 57(8):509–516CrossRef

Kalkman HO, Feuerbach D (2016) Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders. Cell Mol Life Sci 73(13):2511–2530PubMedPubMedCentralCrossRef

Kenk M, Selvanathan T, Rao N, Suridjan I, Rusjan P, Remington G, Meyer JH, Wilson AA, Houle S, Mizrahi R (2015) Imaging neuroinflammation in gray and white matter in schizophrenia: an in vivo PET study with [¹⁸F]-FEPPA. Schizophr Bull 41(1):85–93PubMedCrossRef

Kim S, Nho K, Risacher SL, Inlow M, Swaminathan S, Yoder KK, Shen L, West JD, McDonald BC, Tallman EF, Hutchins GD, Fletcher JW, Farlow MR, Ghetti B, Saykin AJ (2013) PARP1 gene variation and microglial activity on [¹¹C]PBR28 PET in older adults at risk for Alzheimer’s disease. Multimodal Brain Image Anal 8159:150–158CrossRef

Kincaid E (2016) Picture imperfect: going beyond imaging amyloid in Alzheimer’s disease. Nat Med 22(10):1067–1068PubMedCrossRef

Korkhov VM, Sachse C, Short JM, Tate CG (2010) Three-dimensional structure of TspO by electron cryomicroscopy of helical crystals. Structure 18(6):677–687PubMedPubMedCentralCrossRef

Koshimori Y, Ko JH, Mizrahi R, Rusjan P, Mabrouk R, Jacobs MF, Christopher L, Hamani C, Lang AE, Wilson AA, Houle S, Strafella AP (2015) Imaging striatal microglial activation in patients with Parkinson’s disease. PLoS One 10(9):e0138721PubMedPubMedCentralCrossRef

Kreisl WC, Fujita M, Fujimura Y, Kimura N, Jenko KJ, Kannan P, Hong J, Morse CL, Zoghbi SS, Gladding RL, Jacobson S, Oh U, Pike VW, Innis RB (2010) Comparison of [¹¹C]-(R)-PK 11195 and [¹¹C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: implications for positron emission tomographic imaging of this inflammation biomarker. Neuroimage 49(4):2924–2932PubMedCrossRef

Kreisl WC, Jenko KJ, Hines CS, Lyoo CH, Corona W, Morse CL, Zoghbi SS, Hyde T, Kleinman JE, Pike VW, McMahon FJ, Innis RB, Biomarkers Consortium PET Radioligand Project Team (2013a) A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J Cereb Blood Flow Metab 33(1):53–58PubMedCrossRef

Kreisl WC, Lyoo CH, McGwier M, Snow J, Jenko KJ, Kimura N, Corona W, Morse CL, Zoghbi SS, Pike VW, McMahon FJ, Turner RS, Innis RB, Biomarkers Consortium PET Radioligand Project Team (2013b) In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease. Brain 136(Pt 7):2228–2238PubMedPubMedCentralCrossRef

Kreisl WC, Lyoo CH, Liow JS, Wei M, Snow J, Page E, Jenko KJ, Morse CL, Zoghbi SS, Pike VW, Turner RS, Innis RB (2016) ¹¹C-PBR28 binding to translocator protein increases with progression of Alzheimer’s disease. Neurobiol Aging 44:53–61PubMedPubMedCentralCrossRef

Kreisl WC, Lyoo CH, Liow JS, Snow J, Page E, Jenko KJ, Morse CL, Zoghbi SS, Pike VW, Turner RS, Innis RB (2017) Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer’s disease. Neurobiol Aging 51:132–140PubMedCrossRef

Kropholler MA, Boellaard R, Schuitemaker A, van Berckel BN, Luurtsema G, Windhorst AD, Lammertsma AA (2005) Development of a tracer kinetic plasma input model for (R)-[¹¹C]PK11195 brain studies. J Cereb Blood Flow Metab 25(7):842–851PubMedCrossRef

Kropholler MA, Boellaard R, van Berckel BN, Schuitemaker A, Kloet RW, Lubberink MJ, Jonker C, Scheltens P, Lammertsma AA (2007) Evaluation of reference regions for (R)-[¹¹C]PK11195 studies in Alzheimer’s disease and mild cognitive impairment. J Cereb Blood Flow Metab 27(12):1965–1974PubMedCrossRef

Lagarde J, Sarazin M, Chauviré V, Stankoff B, Kas A, Lacomblez L, Peyronneau MA, Bottlaender M (2016) Cholinergic changes in aging and Alzheimer disease: an [¹⁸F]-F-A-85380 exploratory PET study. Alzheimer Dis Assoc Disord. doi:10.1097/WAD.0000000000000163 CrossRef

Laube M, Kniess T, Pietzsch J (2013) Radiolabeled COX-2 inhibitors for non-invasive visualization of COX-2 expression and activity—a critical update. Molecules 18(6):6311–6355PubMedCrossRefPubMedCentral

Lavisse S, Guillermier M, Hérard AS, Petit F, Delahaye M, Van Camp N, Ben Haim L, Lebon V, Remy P, Dollé F, Delzescaux T, Bonvento G, Hantraye P, Escartin C (2012) Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J Neurosci 32(32):10809–10818PubMedCrossRefPubMedCentral

Lavisse S, García-Lorenzo D, Peyronneau MA, Bodini B, Thiriez C, Kuhnast B, Comtat C, Remy P, Stankoff B, Bottlaender M (2015) Optimized quantification of translocator protein radioligand ¹⁸F-DPA-714 uptake in the brain of genotyped healthy volunteers. J Nucl Med 56(7):1048–1054PubMedCrossRef

Liu GJ, Middleton RJ, Hatty CR, Kam WW, Chan R, Pham T, Harrison-Brown M, Dodson E, Veale K, Banati RB (2014) The 18 kDa translocator protein, microglia and neuroinflammation. Brain Pathol 24(6):631–653PubMedCrossRefPubMedCentral

Lockhart A, Davis B, Matthews JC, Rahmoune H, Hong G, Gee A, Earnshaw D, Brown J (2003) The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant alpha1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker. Nucl Med Biol 30:199–206PubMedCrossRef

Lyoo CH, Ikawa M, Liow JS, Zoghbi SS, Morse CL, Pike VW, Fujita M, Innis RB, Kreisl WC (2015) Cerebellum can serve as a pseudo-reference region in Alzheimer disease to detect neuroinflammation measured with PET radioligand binding to translocator protein. J Nucl Med 56(5):701–706PubMedCrossRef

Matthews PM, Datta G (2015) Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis. Expert Opin Drug Discov 10(5):557–570PubMedCrossRef

McEnery MW, Snowman AM, Trifiletti RR, Snyder SH (1992) Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci USA 89:3170–3174PubMedPubMedCentralCrossRef

McGeer PL, McGeer EG (2013) The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol 126(4):479–497PubMedCrossRef

Mishina M, Ishiwata K, Naganawa M, Kimura Y, Kitamura S, Suzuki M, Hashimoto M, Ishibashi K, Oda K, Sakata M, Hamamoto M, Kobayashi S, Katayama Y, Ishii K (2011) Adenosine A(2A) receptors measured with [C]TMSX PET in the striata of Parkinson’s disease patients. PLoS One 6(2):e17338PubMedPubMedCentralCrossRef

Nair A, Veronese M, Xu X, Curtis C, Turkheimer F, Howard R, Reeves S (2016) Test-retest analysis of a non-invasive method of quantifying [¹¹C]-PBR28 binding in Alzheimer’s disease. EJNMMI Res 6(1):72PubMedPubMedCentralCrossRef

Ohnishi A, Senda M, Yamane T, Sasaki M, Mikami T, Nishio T, Ikari Y, Nishida H, Shukuri M, Takashima T, Mawatari A, Doya H, Watanabe Y, Onoe H (2014) Human whole-body biodistribution and dosimetry of a new PET tracer, [¹¹C]ketoprofen methyl ester, for imagings of neuroinflammation. Nucl Med Biol 41(7):594–599PubMedCrossRef

Ohnishi A, Senda M, Yamane T, Mikami T, Nishida H, Nishio T, Akamatsu G, Ikari Y, Kimoto S, Aita K, Sasaki M, Shinkawa H, Yamamoto Y, Shukuri M, Mawatari A, Doi H, Watanabe Y, Onoe H (2016) Exploratory human PET study of the effectiveness of ¹¹C-ketoprofen methyl ester, a potential biomarker of neuroinflammatory processes in Alzheimer’s disease. Nucl Med Biol 43(7):438–444PubMedCrossRef

Okello A, Edison P, Archer HA, Turkheimer FE, Kennedy J, Bullock R, Walker Z, Kennedy A, Fox N, Rossor M, Brooks DJ (2009) Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology 72(1):56–62PubMedPubMedCentralCrossRef

Ory D, Celen S, Gijsbers R, Van Den Haute C, Postnov A, Koole M, Vandeputte C, Andrés JI, Alcazar J, De Angelis M, Langlois X, Bhattacharya A, Schmidt M, Letavic MA, Vanduffel W, Van Laere K, Verbruggen A, Debyser Z, Bormans G (2016) Preclinical evaluation of a P2X7 receptor-selective radiotracer: PET studies in a rat model with local overexpression of the human P2X7 receptor and in nonhuman primates. J Nucl Med 57(9):1436–1441PubMedCrossRef

Owen F, Poulter M, Waddington JL, Mashal RD, Crow TJ (1983) [³H]R05-4864 and [³H]flunitrazepam binding in kainate-lesioned rat striatum and in temporal cortex of brains from patients with senile dementia of the Alzheimer type. Brain Res 278(1–2):373–375PubMedCrossRef

Owen DR, Howell OW, Tang SP, Wells LA, Bennacef I, Bergstrom M, Gunn RN, Rabiner EA, Wilkins MR, Reynolds R, Matthews PM, Parker CA (2010) Two binding sites for [³H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation. J Cereb Blood Flow Metab 30(9):1608–1618PubMedPubMedCentralCrossRef

Owen DR, Gunn RN, Rabiner EA, Bennacef I, Fujita M, Kreisl WC, Innis RB, Pike VW, Reynolds R, Matthews PM, Parker CA (2011) Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med 52(1):24–32PubMedCrossRef

Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, Rhodes C, Pulford DJ, Bennacef I, Parker CA, StJean PL, Cardon LR, Mooser VE, Matthews PM, Rabiner EA, Rubio JP (2012) An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab 32(1):1–5PubMedCrossRef

Pasternak O, Kubicki M, Shenton ME (2016) In vivo imaging of neuroinflammation in schizophrenia. Schizophr Res 173(3):200–212PubMedCrossRef

Perrone M, Moon BS, Park HS, Laquintana V, Jung JH, Cutrignelli A, Lopedota A, Franco M, Kim SE, Lee BC, Denora N (2016) A novel PET imaging probe for the detection and monitoring of translocator protein 18 kDa expression in pathological disorders. Sci Rep 6:20422PubMedPubMedCentralCrossRef

Prokop S, Miller KR, Heppner FL (2013) Microglia actions in Alzheimer’s disease. Acta Neuropathol 126(4):461–477PubMedCrossRef

Raffel J, Sridharan S, Nicholas R (2017) [¹¹C]PBR-28 positron emission tomography in multiple sclerosis: neuroinflammation or otherwise? Ann Neurol 81(2):323–324PubMedCrossRef

Ramanan VK, Risacher SL, Nho K, Kim S, Shen L, McDonald BC, Yoder KK, Hutchins GD, West JD, Tallman EF, Gao S, Foroud TM, Farlow MR, De Jager PL, Bennett DA, Aisen PS, Petersen RC, Jack CR Jr, Toga AW, Green RC, Jagust WJ, Weiner MW, Saykin AJ, Alzheimer’s Disease Neuroimaging Initiative (ADNI) (2015) GWAS of longitudinal amyloid accumulation on ¹⁸F-florbetapir PET in Alzheimer’s disease implicates microglial activation gene IL1RAP. Brain 138(Pt 10):3076–3088PubMedPubMedCentralCrossRef

Rissanen E, Virta JR, Paavilainen T, Tuisku J, Helin S, Luoto P, Parkkola R, Rinne JO, Airas L (2013) Adenosine A2A receptors in secondary progressive multiple sclerosis: a [¹¹C]TMSX brain PET study. J Cereb Blood Flow Metab 33(9):1394–1401PubMedPubMedCentralCrossRef

Rizzo G, Veronese M, Tonietto M, Zanotti-Fregonara P, Turkheimer FE, Bertoldo A (2014) Kinetic modeling without accounting for the vascular component impairs the quantification of [¹¹C]PBR28 brain PET data. J Cereb Blood Flow Metab 34(6):1060–1069PubMedPubMedCentralCrossRef

Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Schöll M, Almkvist O, Wall A, Långström B, Nordberg A (2016a) Comparison of early-phase ¹¹C-deuterium-l-deprenyl and ¹¹C-Pittsburgh compound B PET for assessing brain perfusion in Alzheimer disease. J Nucl Med 57(7):1071–1077PubMedCrossRef

Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Graff C, Wall A, Långström B, Nordberg A (2016b) Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease. Brain 139(Pt 3):922–936PubMedPubMedCentralCrossRef

Roncaroli F, Su Z, Herholz K, Gerhard A, Turkheimer FE (2016) TSPO expression in brain tumours: is TSPO a target for brain tumour imaging? Clin Transl Imaging 4:145–156PubMedPubMedCentralCrossRef

Rusjan PM, Wilson AA, Bloomfield PM, Vitcu I, Meyer JH, Houle S, Mizrahi R (2011) Quantitation of translocator protein binding in human brain with the novel radioligand [¹⁸F]-FEPPA and positron emission tomography. J Cereb Blood Flow Metab 31(8):1807–1816PubMedPubMedCentralCrossRef

Santillo AF, Gambini JP, Lannfelt L, Långström B, Ulla-Marja L, Kilander L, Engler H (2011) In vivo imaging of astrocytosis in Alzheimer’s disease: an ¹¹C-l-deuteriodeprenyl and PIB PET study. Eur J Nucl Med Mol Imaging 38(12):2202–2208PubMedCrossRef

Schöll M, Carter SF, Westman E, Rodriguez-Vieitez E, Almkvist O, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A (2015) Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography. Sci Rep 5:16404PubMedPubMedCentralCrossRef

Schuitemaker A, van Berckel BN, Kropholler MA, Kloet RW, Jonker C, Scheltens P, Lammertsma AA, Boellaard R (2007) Evaluation of methods for generating parametric (R-[¹¹C]PK11195 binding images. J Cereb Blood Flow Metab 27(9):1603–1615PubMedCrossRef

Schuitemaker A, van der Doef TF, Boellaard R, van der Flier WM, Yaqub M, Windhorst AD, Barkhof F, Jonker C, Kloet RW, Lammertsma AA, Scheltens P, van Berckel BN (2012) Microglial activation in healthy aging. Neurobiol Aging 33(6):1067–1072PubMedCrossRef

Schuitemaker A, Kropholler MA, Boellaard R, van der Flier WM, Kloet RW, van der Doef TF, Knol DL, Windhorst AD, Luurtsema G, Barkhof F, Jonker C, Lammertsma AA, Scheltens P, van Berckel BN (2013) Microglial activation in Alzheimer’s disease: an (R)-[¹¹C]PK11195 positron emission tomography study. Neurobiol Aging 34(1):128–136PubMedCrossRef

Schwartz M, Deczkowska A (2016) Neurological disease as a failure of brain-immune crosstalk: the multiple faces of neuroinflammation. Trends Immunol 37(10):668–679PubMedCrossRef

Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, Suridjan I, Kennedy JL, Rekkas PV, Houle S, Meyer JH (2015) Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72(3):268–275PubMedPubMedCentralCrossRef

Slavik R, Müller Herde A, Haider A, Krämer SD, Weber M, Schibli R, Ametamey SM, Mu L (2016) Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2. J Neurochem 138(6):874–886PubMedCrossRef

Srinivasan K, Friedman BA, Larson JL, Lauffer BE, Goldstein LD, Appling LL, Borneo J, Poon C, Ho T, Cai F, Steiner P, van der Brug MP, Modrusan Z, Kaminker JS, Hansen DV (2016) Untangling the brain’s neuroinflammatory and neurodegenerative transcriptional responses. Nat Commun 7:11295PubMedPubMedCentralCrossRef

Stefaniak J, O’Brien J (2016) Imaging of neuroinflammation in dementia: a review. J Neurol Neurosurg Psychiatry 87(1):21–28PubMed

Stephenson DT, Schober DA, Smalstig EB, Mincy RE, Gehlert DR, Clemens JA (1995) Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J Neurosci 15:5263–5274PubMedCrossRefPubMedCentral

Sturm S, Forsberg A, Nave S, Stenkrona P, Seneca N, Varrone A, Comley RA, Fazio P, Jamois C, Nakao R, Ejduk Z, Al-Tawil N, Akenine U, Halldin C, Andreasen N, Ricci B (2016) Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline. Eur J Nucl Med Mol Imaging. doi:10.1007/s00259-016-3510-6 PubMedPubMedCentralCrossRef

Su Z, Herholz K, Gerhard A, Roncaroli F, Du Plessis D, Jackson A, Turkheimer F, Hinz R (2013) [¹¹C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approaches. Eur J Nucl Med Mol Imaging 40(9):1406–1419PubMedPubMedCentralCrossRef

Su L, Blamire AM, Watson R, He J, Hayes L, O’Brien JT (2016a) Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer’s disease and dementia with Lewy bodies. Transl Psychiatry 6(8):e877PubMedPubMedCentralCrossRef

Su L, Faluyi YO, Hong YT, Fryer TD, Mak E, Gabel S, Hayes L, Soteriades S, Williams GB, Arnold R, Passamonti L, Vázquez Rodríguez P, Surendranathan A, Bevan-Jones RW, Coles J, Aigbirhio F, Rowe JB, O’Brien JT (2016b) Neuroinflammatory and morphological changes in late-life depression: the NIMROD study. Br J Psychiatry 209(6):525–526PubMedPubMedCentralCrossRef

Suridjan I, Rusjan PM, Voineskos AN, Selvanathan T, Setiawan E, Strafella AP, Wilson AA, Meyer JH, Houle S, Mizrahi R (2014) Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18 kDa (TSPO) radioligand, [¹⁸F]-FEPPA. Neuroimage 84:868–875PubMedCrossRef

Suridjan I, Pollock BG, Verhoeff NP, Voineskos AN, Chow T, Rusjan PM, Lobaugh NJ, Houle S, Mulsant BH, Mizrahi R (2015) In-vivo imaging of grey and white matter neuroinflammation in Alzheimer’s disease: a positron emission tomography study with a novel radioligand, [¹⁸F]-FEPPA. Mol Psychiatry 20(12):1579–1587PubMedCrossRefPubMedCentral

Takata K, Kato H, Shimosegawa E, Okuno T, Koda T, Sugimoto T, Mochizuki H, Hatazawa J, Nakatsuji Y (2014) ¹¹C-acetate PET imaging in patients with multiple sclerosis. PLoS One 9(11):e111598PubMedPubMedCentralCrossRef

Tang Y, Le W (2016) Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol 53(2):1181–1194PubMedCrossRef

Tanzi RE (2015) TREM2 and risk of Alzheimer’s disease-friend or foe? N Engl J Med 372(26):2564–2565PubMedCrossRef

Temel SG, Kahveci Z (2009) Cyclooxygenase-2 expression in astrocytes and microglia in human oligodendroglioma and astrocytoma. J Mol Histol 40(5–6):369–377PubMedCrossRef

Terada T, Yokokura M, Yoshikawa E, Futatsubashi M, Kono S, Konishi T, Miyajima H, Hashizume T, Ouchi Y (2016) Extrastriatal spreading of microglial activation in Parkinson’s disease: a positron emission tomography study. Ann Nucl Med 30(8):579–587PubMedCrossRef

Territo PR, Meyer JA, Peters JS, Riley AA, McCarthy BP, Gao M, Wang M, Green MA, Zheng QH, Hutchins GD (2017) Characterization of [¹¹C]-GSK1482160 for targeting the P2X7 receptor as a biomarker for neuroinflammation. J Nucl Med 58:458–465PubMedCrossRef

Thériault P, ElAli A, Rivest S (2015) The dynamics of monocytes and microglia in Alzheimer’s disease. Alzheimers Res Ther 7(1):41PubMedPubMedCentralCrossRef

Tomasi G, Edison P, Bertoldo A, Roncaroli F, Singh P, Gerhard A, Cobelli C, Brooks DJ, Turkheimer FE (2008) Novel reference region model reveals increased microglial and reduced vascular binding of ¹¹C-(R)-PK11195 in patients with Alzheimer’s disease. J Nucl Med 49(8):1249–1256PubMedCrossRef

Toyohara J, Sakata M, Hatano K, Yanai S, Endo S, Ishibashi K, Wagatsuma K, Ishii K, Ishiwata K (2016) Preclinical and first-in-man studies of [¹¹C]CB184 for imaging the 18-kDa translocator protein by positron emission tomography. Ann Nucl Med 30(8):534–543PubMedCrossRef

Turkheimer FE, Edison P, Pavese N, Roncaroli F, Anderson AN, Hammers A, Gerhard A, Hinz R, Tai YF, Brooks DJ (2007) Reference and target region modeling of [¹¹C]-(R)-PK11195 brain studies. J Nucl Med 48(1):158–167PubMed

Turkheimer FE, Rizzo G, Bloomfield PS, Howes O, Zanotti-Fregonara P, Bertoldo A, Veronese M (2015) The methodology of TSPO imaging with positron emission tomography. Biochem Soc Trans 43(4):586–592PubMedPubMedCentralCrossRef

Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, Leigh PN, Banati RB (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [¹¹C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15(3):601–609PubMedCrossRef

van Dyck CH (2008) Imaging microglial activation in Alzheimer’s disease: what does it mean? Biol Psychiatry 64(10):833–834PubMedCrossRef

Varrone A, Mattsson P, Forsberg A, Takano A, Nag S, Gulyás B, Borg J, Boellaard R, Al-Tawil N, Eriksdotter M, Zimmermann T, Schultze-Mosgau M, Thiele A, Hoffmann A, Lammertsma AA, Halldin C (2013) In vivo imaging of the 18-kDa translocator protein (TSPO) with [¹⁸F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients. Eur J Nucl Med Mol Imaging 40(6):921–931PubMedCrossRef

Varrone A, Oikonen V, Forsberg A, Joutsa J, Takano A, Solin O, Haaparanta-Solin M, Nag S, Nakao R, Al-Tawil N, Wells LA, Rabiner EA, Valencia R, Schultze-Mosgau M, Thiele A, Vollmer S, Dyrks T, Lehmann L, Heinrich T, Hoffmann A, Nordberg A, Halldin C, Rinne JO (2015) Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [¹⁸F]FEMPA in Alzheimer’s disease patients and control subjects. Eur J Nucl Med Mol Imaging 42(3):438–446PubMedCrossRef

Venneti S, Lopresti BJ, Wiley CA (2006) The peripheral benzodiazepine receptor (Translocator protein 18 kDa) in microglia: from pathology to imaging. Prog Neurobiol 80(6):308–322PubMedPubMedCentralCrossRef

Venneti S, Wang G, Nguyen J, Wiley CA (2008) The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders. J Neuropathol Exp Neurol 67(10):1001–1010PubMedCrossRef

Venneti S, Wiley CA, Kofler J (2009) Imaging microglial activation during neuroinflammation and Alzheimer’s disease. J Neuroimmune Pharmacol 4(2):227–243PubMedCrossRef

Versijpt JJ, Dumont F, Van Laere KJ, Decoo D, Santens P, Audenaert K, Achten E, Slegers G, Dierckx RA, Korf J (2003) Assessment of neuroinflammation and microglial activation in Alzheimer’s disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study. Eur Neurol 50(1):39–47PubMedCrossRef

Vivash L, O’Brien TJ (2016) Imaging microglial activation with TSPO PET: lighting up neurologic diseases? J Nucl Med 57(2):165–168PubMedCrossRef

Wang HY, Lee DH, D’Andrea MR, Peterson PA, Shank RP, Reitz AB (2000) Beta-amyloid (1–42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer’s disease pathology. J Biol Chem 275:5626–5632PubMedCrossRef

Weissman BA, Bolger GT, Isaac L, Paul SM, Skolnick P (1984) Characterization of the binding of [³H]Ro 5-4864, a convulsant benzodiazepine, to guinea pig brain. J Neurochem 42:969–975PubMedCrossRef

Wiley CA, Lopresti BJ, Venneti S, Price J, Klunk WE, DeKosky ST, Mathis CA (2009) Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease. Arch Neurol 66(1):60–67PubMedPubMedCentralCrossRef

Wimberley C, Lavisse S, Peyronneau M-A, Stute S, Reilhac A, Brulon V, Comtat C, Leroy C, Remy P, Stankoff B, Buvat I, Bottlaender M (2016) Impact of vascular trapping of ¹⁸F-DPA-714 on binding parameter estimates in the healthy human. In: NeuroReceptorMapping meeting, O-021

Yaqub M, van Berckel BN, Schuitemaker A, Hinz R, Turkheimer FE, Tomasi G, Lammertsma AA, Boellaard R (2012) Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[¹¹C]PK11195 brain PET studies. J Cereb Blood Flow Metab 32(8):1600–1608PubMedPubMedCentralCrossRef

Yasuno F, Ota M, Kosaka J, Ito H, Higuchi M, Doronbekov TK, Nozaki S, Fujimura Y, Koeda M, Asada T, Suhara T (2008) Increased binding of peripheral benzodiazepine receptor in Alzheimer’s disease measured by positron emission tomography with [¹¹C]DAA1106. Biol Psychiatry 64(10):835–841PubMedCrossRef

Yasuno F, Kosaka J, Ota M, Higuchi M, Ito H, Fujimura Y, Nozaki S, Takahashi S, Mizukami K, Asada T, Suhara T (2012) Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [¹¹C]DAA1106. Psychiatry Res 203(1):67–74PubMedCrossRef

Yoder KK, Nho K, Risacher SL, Kim S, Shen L, Saykin AJ (2013) Influence of TSPO genotype on ¹¹C-PBR28 standardized uptake values. J Nucl Med 54(8):1320–1322PubMedCrossRef

Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y, Wakuda T, Sugihara G, Takebayashi K, Suda S, Iwata Y, Ueki T, Tsuchiya KJ, Suzuki K, Nakamura K, Ouchi Y (2011) In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease. Eur J Nucl Med Mol Imaging 38(2):343–351PubMedCrossRef

Yokokura M, Terada T, Bunai T, Nakaizumi K, Takebayashi K, Iwata Y, Yoshikawa E, Futatsubashi M, Suzuki K, Mori N, Ouchi Y (2017) Depiction of microglial activation in aging and dementia: Positron emission tomography with [¹¹C]DPA713 versus [¹¹C](R)PK11195. J Cereb Blood Flow Metab 37:877–889PubMedCrossRef

Zahr NM, Mayer D, Rohlfing T, Sullivan EV, Pfefferbaum A (2014) Imaging neuroinflammation? A perspective from MR spectroscopy. Brain Pathol 24(6):654–664PubMedPubMedCentralCrossRef

Zeineh MM, Chen Y, Kitzler HH, Hammond R, Vogel H, Rutt BK (2015) Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease. Neurobiol Aging 36(9):2483–2500PubMedPubMedCentralCrossRef

Zhang J (2015) Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging. J Neuroinflammation 12:108PubMedPubMedCentralCrossRef

Zhang H, Schneider T, Wheeler-Kingshott CA, Alexander DC (2012) NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage 61(4):1000–1016PubMedCrossRef

Zimmer ER, Leuzy A, Benedet AL, Breitner J, Gauthier S, Rosa-Neto P (2014) Tracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imaging. J Neuroinflammation 11:120PubMedPubMedCentralCrossRef

Zürcher NR, Loggia ML, Lawson R, Chonde DB, Izquierdo-Garcia D, Yasek JE, Akeju O, Catana C, Rosen BR, Cudkowicz ME, Hooker JM, Atassi N (2015) Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [¹¹C]-PBR28. Neuroimage Clin 7:409–414PubMedPubMedCentralCrossRef

Titel: In vivo PET imaging of neuroinflammation in Alzheimer’s disease
verfasst von: Julien Lagarde
Marie Sarazin
Michel Bottlaender
Publikationsdatum: 17.05.2017
Verlag: Springer Vienna
Erschienen in: Journal of Neural Transmission / Ausgabe 5/2018
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-017-1731-x

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

In vivo PET imaging of neuroinflammation in Alzheimer’s disease

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Neuroinflammatory responses in Alzheimer’s disease

Innate immunity in Alzheimer’s disease: the relevance of animal models?

Kynurenine is correlated with IL-1β in plasma of schizophrenia patients

Let’s make microglia great again in neurodegenerative disorders

Differential contribution of microglia and monocytes in neurodegenerative diseases

Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer’s disease

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie